Michael Gnant
Impact in
- Cancer Research top 0.01%
- Breast Cancer Treatment Studies
- Oncology top 0.1%
- Bone health and treatments
- HER2/EGFR in Cancer Research
Papers in
- Cancer Research 224
- Breast Cancer Treatment Studies 219
- Oncology 166
- Bone health and treatments 57
- HER2/EGFR in Cancer Research 37
- Co-authors
- Nadia Harbeck (16 shared papers)R. Jakesz (137 shared papers)Rury R. Holman (1 shared paper)C A Cull (1 shared paper)IRENE M. STRATTON (1 shared paper)Charles Fox (1 shared paper)Matthews (1 shared paper)E M Kohner (1 shared paper)
- Journals
- Annals of Oncology (43 papers)Breast Care (28 papers)European Journal of Cancer (25 papers)Breast Cancer Research and Treatment (23 papers)Journal of Clinical Oncology (20 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Michael Gnant
527 papers receiving 58.1k citations
Michael Gnant's Hit Papers
Peers
Comparison fields: 5 of 177
- Cancer Research 19.3k
- Oncology 10.6k
- Endocrinology, Diabetes and Metabolism 5.6k
- Pulmonary and Respiratory Medicine 5.3k
- Surgery 6.6k
Countries citing papers authored by Michael Gnant
This map shows the geographic impact of Michael Gnant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gnant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gnant more than expected).
Fields of papers citing papers by Michael Gnant
This network shows the impact of papers produced by Michael Gnant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gnant. The network helps show where Michael Gnant may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Gnant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 550 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Hit paper breakdown → | 1998 | 7506 |
| 2 | Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Hit paper breakdown → | 1994 | 7349 |
| 3 | Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Hit paper breakdown → | 2013 | 2987 |
| 4 | Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2011 | 2400 |
| 5 | Breast cancer Hit paper breakdown → | 2019 | 2282 |
| 6 | Breast cancer Hit paper breakdown → | 2016 | 1910 |
| 7 | Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Hit paper breakdown → | 1998 | 1908 |
| 8 | Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Hit paper breakdown → | 1991 | 1632 |
| 9 | Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Hit paper breakdown → | 2015 | 1470 |
| 10 | De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Hit paper breakdown → | 2017 | 918 |
| 11 | Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials Hit paper breakdown → | 2017 | 859 |
| 12 | Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer Hit paper breakdown → | 2009 | 856 |
| 13 | 2005 | 714 | |
| 14 | 2009 | 649 | |
| 15 | Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 Hit paper breakdown → | 2021 | 583 |
| 16 | 2011 | 555 | |
| 17 | Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2023 | 544 |
| 18 | Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019 Hit paper breakdown → | 2019 | 530 |
| 19 | Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 Hit paper breakdown → | 2014 | 478 |
| 20 | 2017 | 469 |
About Michael Gnant
Michael Gnant is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Hepatology and Transplantation, having authored 550 papers that have together received 60.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (219 papers), Advanced Breast Cancer Therapies (61 papers), Bone health and treatments (57 papers), HER2/EGFR in Cancer Research (37 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Breast Implant and Reconstruction (14 papers), Breast Lesions and Carcinomas (14 papers) and Immunotherapy and Immune Responses (14 papers). The work is most often cited by research in Cancer Research (19.3k citations), Oncology (10.6k citations), Endocrinology, Diabetes and Metabolism (5.6k citations), Pulmonary and Respiratory Medicine (5.3k citations) and Surgery (6.6k citations). Michael Gnant has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Nadia Harbeck, R. Jakesz, Rury R. Holman, C A Cull, IRENE M. STRATTON, Charles Fox, Matthews, E M Kohner, R. C. Turner and Donna Wright. Their work appears in journals such as Annals of Oncology, Breast Care, European Journal of Cancer, Breast Cancer Research and Treatment and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.